Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA)

Molecules

Volumn 17, Issue 9, 2012, Pages 10322-10330

  Zuo, Guo Ying ^a   Li, Yang ^a,b   Han, Jun ^c   Wang, Gen Chun ^a   Zhang, Yun Ling ^a   Bian, Zhong Qi ^a  

^a KUNMING GENERAL HOSPITAL   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c YUNNAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

8 acetonyl dihydroberberine; Anti MRSA; FICI; Levofloxacin; Synergy

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BERBERINE; CEFAZOLIN; OFLOXACIN;

ARTICLE; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; DRUG POTENTIATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE;

AMPICILLIN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BERBERINE; CEFAZOLIN; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN;

EID: 84866950181     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules170910322     Document Type: Article

References (26)

1. Jevons, M.P. "Celbenin"-resistant staphylococci. Br. Med. J. 1961, 124, 124-125.
2. Chang, S.; Sievert, D.M.; Hageman, J.C.; Boulton, M.L.; Tenover, F.C.; Downes, F.P.; Shah, S.; Rudrik, J.T.; Pupp, G.R.; Brown, W.J.; et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 2003, 348, 1342-1347.
3. Mahady, G.B. Medicinal plants for the prevention and treatment of bacterial infections. Curr. Pharm. Des. 2005, 11, 2405-2427.
4. Gibbons, S. Anti-Staphylococcal plant natural products. Nat. Prod. Rep. 2004, 21, 263-277.
5. Gibbons, S. Phytochemicals for bacterial resistance-strengths, weaknesses and opportunities. Planta Med. 2008, 74, 594-602.
6. Zuo, G.-Y.; Meng, F.-Y.; Hao, X.-Y.; Zhang, Y.-L.; Wang, G.-C.; Xu, G.-L. Antibacterial alkaloids from Chelidonium majus Linn (Papaveraceae) against clinical isolates of methicillinresistant Staphylococcus aureus. J. Pharm. Pharm. Sci. 2008, 11, 90-94.
7. Zuo, G.-Y.; Wang, G.-C.; Zhao, Y.-B.; Xu, G.-L.; Hao, X.-Y.; Han, J.; Zhao, Q. Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). J. Ethnopharmacol. 2008, 120, 287-290.
8. Zuo, G.-Y.; Zhang, X.-J.; Yang, C.-X.; Han, J.; Wang, G.-C.; Bian, Z.-Q. Evaluation of traditional Chinese medicinal plants for anti-MRSA activity with reference to the treatment record of infectious diseases. Molecules 2012, 17, 2955-2967.
9. Zuo, G.-Y.; Li, Y.; Wang, T.; Han, J.; Wang, G.-C.; Zhang, Y.-L.; Pan, W.-D. Synergistic antibacterial and antibacterial agent effects of bisbenzylisoquinoline alkaloids on clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Molecules 2011, 16, 9819-9826.
10. An, J.; Zuo, G.-Y.; Hao, X.-Y.; Wang, G.-C.; Li, Z.-S. Antibacterial and synergy of a flavanonol rhamnoside with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Phytomedicine 2011, 18, 990-993.
11. Yu, H.H.; Kim, K.J.; Cha, J.D.; Kim, H.K.; Lee, Y.E.; Choi, N.Y.; You, Y.O. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillinresistant Staphylococcus aureus. J. Med. Food 2005, 8, 454-461.
12. Inoue, K.; Kulsum, U.; Chowdhury, S.A.; Fujisawa, S.-I.; Ishihara, M.; Yokoe, I.; Sakagam, H. Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines. Anticancer Res. 2005, 25, 4053-4060.
13. McDonald, M.; Dougall, A.; Holt, D.; Huygens, F.; Oppedisano, F.; Giffard, P.M.; Inman-Bamber, J.; Stephens, A.J.; Towers, R.; Carapetis, J.R. Use of single nucleotide polymorphism (SNP) genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote Aboriginal communities. J. Clin. Microbiol. 2006, 44, 3720-3727.
14. Petersen, P.J.; Labthavikul, P.; Jones, C.H.; Bradford, P.A. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J. Antimicrob. Chemother. 2006, 57, 573-576.
15. Wagner, H.; Ulrich-Merzenich, G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16, 97-110.
16. Stavri, M.; Piddock, L.J.V.; Gibbons, S. Bacterial efflux pump inhibitors from natural sources. J. Antimicrob. Chemother. 2007, 59, 1247-1260.
17. Hemaiswarya, S.; Kruthiventi, A.K.; Doble, M. Synergism between natural products and antibacterial agents against infectious diseases. Phytomedicine 2008, 15, 639-652.
18. Onda, M.; Yuasa, K.; Okada, J.; Kataoka, K.; Abe, K. Utilization of protopine and related alkaloids. VI. Chem. Pharm. Bull. 1973, 21, 1333-1337.
19. Kloos, W.K.; Bannerman, T.L. Staphylococcus and Micrococcus. In Manual of Clinical Microbiology, 7th ed.; Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C., Yolken, R.H., Eds.; ASM Press: Washington, DC, USA, 1999; pp. 264-282.
20. Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved standard; CLSI: Wayne, PA, USA, 2006.
21. Performance Standards for Antimicrobial Susceptibility Tests, 17th informational supplement; CLSI: Wayne, PA, USA, 2007.
22. Zhang, K.; McClure, J.A.; Elsayed, S.; Louie, T.; Conly, J.M. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 2005, 43, 5026-5033.
23. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 7th ed.; CLSI: Wayne, PA, USA, 2006.
24. Methods for Determining Bactericidal Activity of Antimicrobial Agents, Approved Guideline; CLSI: Wayne, PA, USA, 1999.
25. Hu, Z.Q.; Zhao, W.H.; Asano, N.; Yoda, Y.; Hara, Y.; Shimamura, T. Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2002, 46, 558-560.
26. Chin, J.N.; Jones, R.N.; Sader, H.S.; Savage, P.B.; Rybak, M.J. Potential synergy activity of the novel ceragenin, CAS-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. J. Antimicrob. Chemother. 2008, 61, 365-370.